BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28444881)

  • 1. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.
    Song P; Jiang B; Liu Z; Ding J; Liu S; Guan W
    Cancer Med; 2017 Jun; 6(6):1154-1164. PubMed ID: 28444881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long non-coding RNA signature to improve prognosis prediction of gastric cancer.
    Zhu X; Tian X; Yu C; Shen C; Yan T; Hong J; Wang Z; Fang JY; Chen H
    Mol Cancer; 2016 Sep; 15(1):60. PubMed ID: 27647437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
    Ren W; Zhang J; Li W; Li Z; Hu S; Suo J; Ying X
    Med Sci Monit; 2016 Oct; 22():3647-3657. PubMed ID: 27727196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
    Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
    Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
    J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
    Cheng P
    J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
    Zhao J; Xu J; Shang AQ; Zhang R
    Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-long non-coding RNA signature in predicting breast cancer survival.
    Meng J; Li P; Zhang Q; Yang Z; Fu S
    J Exp Clin Cancer Res; 2014 Oct; 33(1):84. PubMed ID: 25288503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.